Viracta Therapeutics (VIRX) Financials

$0.01

$-0.03 (-72.16%)

As on 30-Dec-2025 16:00EDT

Market cap

$0 Mln

Revenue (TTM)

$1 Mln

P/E Ratio

--

P/B Ratio

3

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Operating Revenue	0.74	--	--	--	0.12	2.07
Cost of Revenue	0.33	0.49	0.21	0.18	0.03	--
Gross Profit	0.41	-0.49	-0.21	-0.18	0.09	2.07
Operating Expenses	46.98	50.69	50.59	25.80	18.82	25.36
Operating Profit (EBIT)	-47.21	-50.69	-50.59	62.50	-18.82	-23.29
Other Income	--	--	1.21	-0.49	1.00	--
Profit before Tax	-43.29	-51.06	-49.20	-114.76	-19.02	-23.33
Provision for Tax	-0.48	--	0.58	88.30	0.18	0.51
Profit after Tax (Net Income)	-43.29	-51.06	-49.77	-203.06	-19.20	-23.33
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	-49.20	-114.76	-19.02	-13.56

Liabilities ($ Mln)	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Shareholder's Funds	-6.62	18.32	61.10	94.37	-46.20	27.54
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	--	--	24.88	5.10	88.22	0.28
Current Liabilities	28.58	38.37	10.01	9.08	6.28	9.42
Total Liabilities	50.53	56.69	95.99	108.55	48.31	37.24

Assets ($ Mln)	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Non-Current Assets	0.16	1.73	2.24	3.28	1.11	0.92
Current Assets	21.80	54.96	93.75	105.27	47.20	36.32
Total Assets	50.53	56.69	95.99	108.55	48.31	37.24
Total Debt*	16.91	25.56	25.16	5.48	6.18	6.28
Net Current Assets	-6.77	16.59	83.74	96.19	40.92	--

Cashflow ($ Mln)	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Cash From Operating Activities	--	-39.89	-35.46	-18.85	-16.05	-22.19
Cash Flow from Investing Activities	--	15.00	-53.87	12.89	-0.06	-16.29
Cash from Financing Activities	--	0.44	22.54	62.43	44.98	43.04
Net Cash Inflow / Outflow	--	--	-66.78	56.47	2.15	--

Financials Ratios	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Adjusted EPS ($)	-1.10	-1.32	-1.30	-5.42	-0.52	-2.10
Cash EPS ($)	--	-1.31	-1.29	-5.42	-0.52	-2.10
Adjusted Book Value ($)	--	0.47	1.59	2.52	--	2.47
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-1.03	-0.93	-0.50	-0.43	-1.99
Free Cash Flow per Share ($)	--	-1.03	-0.93	-0.62	-0.43	-1.99

Profitability Ratios	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
ROCE (%)	--	-78.47	-53.49	-678.83	619.62	-103.20
ROE (%)	--	-128.57	-64.03	-843.09	205.81	-147.96
ROA (%)	-56.44	-66.88	-48.67	-258.91	-44.89	-88.77
EBIT Margin (%)	-5,434.42	--	--	--	-15,667.50	-1,100.63
Net Margin (%)	-5,865.72	--	-4,100.00	41,782.30	-1,721.88	-1,125.42
Cash Profit Margin (%)	-0.01	--	--	--	--	--

Growth Ratios	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Revenue Growth (%)	--	--	--	-1.00	-0.94	7.75
EBIT Growth (%)	10.23	6.39	55.73	-507.79	17.60	10.39
Net Profit Growth (%)	9.45	-2.58	75.49	-957.67	17.71	12.34
EPS Growth (%)	11.11	-0.01	0.76	-9.50	0.75	0.71
Book Value Growth (%)	-121.55	--	--	--	--	--

Valuation Ratios	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Price / Earnings	--	-0.43	-1.12	-0.67	-3.85	-0.16
Price / Book Value	3.00	1.21	0.92	1.45	-1.60	0.14
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-0.48	0.13	0.20	-0.34	-1.76	1.08
Close Price ($)	0.23	0.57	1.46	3.65	6.97	11.82
High Price ($)	1.31	2.47	5.75	24.80	39.55	61.95
Low Price ($)	0.20	0.43	1.21	3.18	3.92	6.83
Market Cap ($ Cr)	0.39	--	--	--	--	--

Solvency Ratios	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Debt to Equity	--	1.40	0.41	0.06	-0.13	0.23
Short term debt to equity ratio	-2.56	1.40	0.01	0.00	-0.03	0.22
Current Ratio	0.76	1.43	9.36	11.59	7.51	3.86
Quick Ratio	0.76	1.44	9.46	--	--	--
Interest Coverage	-12.60	-12.78	-87.68	-232.73	-87.04	-44.39

Operating Efficiency Ratios	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Debtors to sales (%)	--	--	--	--	--	--
Asset Turnover	0.01	--	--	--	0.00	0.08
Receivable days	--	--	--	--	--	--
Inventory Days	--	-387.89	-1,582.75	--	--	--
Payable days	--	1,848.89	4,731.73	4,573.83	13,400.11	--
Cash Conversion Cycle	--	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.